These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1110359)

  • 1. Injection of 6-hydroxydopamine and hydrogen peroxide into the substantia nigra and lateral ventricle of the cat: specific and nonspecific effects on striatal biogenic amines.
    Stahl SM; Daniels AC; Derda D; Spehlmann R
    J Neurochem; 1975 Jan; 24(1):165-72. PubMed ID: 1110359
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-Hydroxydopamine and striatal acetylcholine levels.
    Grewaal DS; Fibiger HC; McGeer EG
    Brain Res; 1974 Jun; 73(2):372-5. PubMed ID: 4151550
    [No Abstract]   [Full Text] [Related]  

  • 3. Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
    Agid Y; Javoy F; Glowinski J; Bouvet D; Sotelo C
    Brain Res; 1973 Aug; 58(2):291-301. PubMed ID: 4756131
    [No Abstract]   [Full Text] [Related]  

  • 4. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 6-hydroxydopamine on the nature of proteins undergoing axoplasmic transport in nigro-neostriatal neurons.
    Singh VK; Fibiger HC; McGeer PL
    J Neurochem; 1974 Sep; 23(3):601-4. PubMed ID: 4153672
    [No Abstract]   [Full Text] [Related]  

  • 6. Substantia nigra and the sensorimotor system (chemonigrectomies induced by intrategmental administration of the paraquinone of 6-hydroxy-dopamine and 6,7-dihydroxitryptamine in the cat and monkey.).
    Frigyesi TL; Tsukamoto Y; Ige A; Cohen L; Szabo J
    Int J Neurol; 1975; 10(1-4):98-114. PubMed ID: 810445
    [No Abstract]   [Full Text] [Related]  

  • 7. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
    Filloux FM; Wamsley JK; Dawson TM
    Eur J Pharmacol; 1987 Jun; 138(1):61-8. PubMed ID: 3113982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuraminergic conception of extrapyramidal syndromology].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):293-9. PubMed ID: 139066
    [No Abstract]   [Full Text] [Related]  

  • 12. Depletion of striatal beta-phenylethylamine following dopamine but not 5-HT denervation.
    Greenshaw AJ; Juorio AV; Nguyen TV
    Brain Res Bull; 1986 Oct; 17(4):477-84. PubMed ID: 3096499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monkeys with nigrostriatal lesions effects of monoaminergic drugs.
    Goldstein M; Anagnoste B; Battista AF; Ogawa M
    Pharmacol Ther B; 1976; 2(1):97-103. PubMed ID: 817335
    [No Abstract]   [Full Text] [Related]  

  • 14. Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus.
    Portig PJ; Vogt M
    J Physiol; 1969 Oct; 204(3):687-715. PubMed ID: 4309959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
    Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal monoamines and reserpine and chlorpromazine rigidity.
    Jurna I
    Pharmacol Ther B; 1976; 2(1):113-28. PubMed ID: 178006
    [No Abstract]   [Full Text] [Related]  

  • 17. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA; Grünewald RA; Foley P; Shaw SG
    J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
    Chiueh CC; Moore KE
    Brain Res; 1973 Feb; 50(1):221-5. PubMed ID: 4690549
    [No Abstract]   [Full Text] [Related]  

  • 20. Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    J Pharmacol Exp Ther; 1979 Oct; 211(1):189-94. PubMed ID: 573788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.